Target Name: UNC5B
NCBI ID: G219699
Review Report on UNC5B Target / Biomarker Content of Review Report on UNC5B Target / Biomarker
UNC5B
Other Name(s): protein unc-5 homolog 2 | Unc-5 netrin receptor B, transcript variant 1 | UNC5H2 | UNC5B variant 1 | transmembrane receptor Unc5H2 | p53-regulated receptor for death and life protein 1 | Netrin receptor UNC5B | Protein unc-5 homolog 2 | UNC5B_HUMAN | Protein unc-5 homolog B | Unc5 (C.elegans homolog) b | unc-5 homolog 2 | protein unc-5 homolog B | p53RDL1 | p53-regulated receptor for death and life | Netrin receptor UNC5B (isoform 1) | Unc-5 homolog 2 | Transmembrane receptor Unc5H2 | unc-5 homolog B | unc-5 netrin receptor B | Netrin receptor UNC5B [Precursor]

UNC5B: A promising Protein Unc-5 Homolog 2 (UNC5B) as a Drug Target and Biomarker

Unc-5B (protein unc-5 homolog 2) is a gene located on chromosome 16, which has been shown to be involved in various cellular processes. Its primary function is to encode a protein that is similar to other proteins in the unc-5 family, which are known to play a crucial role in regulating gene expression and cell signaling pathways. However, the exact function of Unc-5B is not well understood, and its potential role in various biological processes remains unexplored.

Recent studies have suggested that Unc-5B may have a significant impact on various cellular processes, including cell growth, apoptosis, and inflammation. It has been shown to play a role in the regulation of cell cycle progression, cell adhesion, and the response to various signaling pathways.

As a Drug Target

Drug targets are proteins that are associated with a specific disease or condition and are targeted by drugs to inhibit their activity. Unc-5B is a potential drug target due to its involvement in various cellular processes that are associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key reasons for identifying Unc-5B as a potential drug target is its role in the regulation of cell cycle progression. The cell cycle is the process by which cells grow, divide, and replicate their genetic material. Mutations in the cell cycle can lead to the development of cancer. Unc-5B has been shown to play a role in regulating the cell cycle by preventing the accumulation of mutations that can accumulate during the cell cycle.

In addition to its role in cell cycle regulation, Unc-5B has also been shown to be involved in the regulation of cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. The regulation of cell adhesion is critical for the development and maintenance of tissues and organs, and is often disrupted in various diseases, including cancer.

Unc-5B has also been shown to play a role in the regulation of the immune response. The immune response is the process by which the body defends itself against foreign substances, including bacteria, viruses, and cancer cells. Unc-5B has been shown to play a role in regulating the production of immune cells, which are critical for the immune response.

As a Biomarker

In addition to its potential as a drug target, Unc-5B has also been suggested as a potential biomarker for various diseases. The function of Unc-5B is often disrupted in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The decreased activity of Unc-5B has been observed in various diseases, which may be used as a biomarker to track the progression of these diseases.

One of the key advantages of using Unc-5B as a biomarker is its stability. Unlike many other proteins, Unc-5B is a stable protein that can be used as a biomarker for a long period of time. This stability is important for the development of diagnostic tests that are based on Unc-5B as a biomarker.

In conclusion, Unc-5B is a gene that has been shown to be involved in various cellular processes. Its potential as a drug target and biomarker makes it an attractive target for further research. As research continues to uncover the functions of Unc-5B, its potential in the development of new treatments for various diseases will be further explored.

Protein Name: Unc-5 Netrin Receptor B

Functions: Receptor for netrin required for axon guidance. Mediates axon repulsion of neuronal growth cones in the developing nervous system upon ligand binding. Axon repulsion in growth cones may be caused by its association with DCC that may trigger signaling for repulsion (By similarity). Functions as netrin receptor that negatively regulates vascular branching during angiogenesis. Mediates retraction of tip cell filopodia on endothelial growth cones in response to netrin (By similarity). It also acts as a dependence receptor required for apoptosis induction when not associated with netrin ligand (PubMed:12598906). Mediates apoptosis by activating DAPK1. In the absence of NTN1, activates DAPK1 by reducing its autoinhibitory phosphorylation at Ser-308 thereby increasing its catalytic activity (By similarity)

The "UNC5B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UNC5B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

UNC5B-AS1 | UNC5C | UNC5CL | UNC5D | UNC79 | UNC80 | UNC93A | UNC93B1 | UNC93B2 | UNC93B3 | UNC93B5 | Uncharactered LOC400863 | Uncharacterized FLJ44790 | Uncharacterized LOC101927121, transcript variant X1 | Uncharacterized LOC101928822, transcript variant X1 | Uncharacterized LOC101929670, transcript variant X1 | Uncharacterized LOC102723888, transcript variant X1 | Uncharacterized LOC102724782, transcript variant X2 | Uncharacterized LOC102724946, transcript variant X3 | Uncharacterized LOC105371833, transcript variant X2 | Uncharacterized LOC105372229, transcript variant X1 | Uncharacterized LOC105373166, transcript variant X2 | Uncharacterized LOC105373806, transcript variant X1 | Uncharacterized LOC105374567, transcript variant X2 | Uncharacterized LOC105374812, transcript variant X2 | Uncharacterized LOC105375163, transcript variant X1 | Uncharacterized LOC105376875, transcript variant X2 | Uncharacterized protein BC001742 | Uncharacterized protein FLJ23867 | Uncharacterized protein MGC16142 | Uncharacterized protein MGC27345 | UNCX | UNG | Uniplex complex | UNK | UNKL | UNQ9370 | UOX | UPB1 | UPF1 | UPF2 | UPF3A | UPF3B | UPK1A | UPK1A-AS1 | UPK1B | UPK2 | UPK3A | UPK3B | UPK3BL1 | UPP1 | UPP2 | UPRT | UQCC1 | UQCC2 | UQCC3 | UQCC4 | UQCC5 | UQCC6 | UQCR10 | UQCR10P1 | UQCR11 | UQCRB | UQCRBP1 | UQCRC1 | UQCRC2 | UQCRC2P1 | UQCRFS1 | UQCRFS1P1 | UQCRH | UQCRHL | UQCRQ | URAD | URAHP | URB1 | URB1-AS1 | URB2 | Urea transporter | URGCP | URGCP-MRPS24 | URI1 | Uridine phosphorylase | URM1 | UROC1 | UROD | UROS | USB1 | USE1 | USF1 | USF2 | USF3 | USH1C | USH1G | USH2A | USHBP1 | USO1 | USP1 | USP1-UAF1 complex | USP10 | USP11